migraine in metabolic syndrome

Neurologist

Volumn 15, Issue 2, 2009, Pages 55-58

  Guldiken, Baburhan ^a,c   Guldiken, Sibel ^a   Taskiran, Bengur ^a   Koc, Gonul ^b   Turgut, Nilda ^a   Kabayel, Levent ^b   Tugrul, Armagan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b Social Security Hospital   (Turkey)

^c Demirkapi Mevki Ktrkareli Yolu ̈Uzeri ^*  (Turkey)

Author keywords

Diabetes mellitus; Metabolic syndrome; Migraine; Obesity; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIGRAINE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; AGED; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MIGRAINE DISORDERS; PREVALENCE; SEX FACTORS; YOUNG ADULT;

EID: 63449123503     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31817781b6     Document Type: Article

References (36)

1. Scher AI, Terwindt GM, Picavet HS, et al. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology. 2005;64:614-620.
2. Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: the atherosclerosis risk in communities study. Neurology. 2005; 64:1573-1577.
3. Merikangas KR, Fenton BT, Cheng SH, et al. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol. 1997;54:362-368.
4. Cook NR, Bensenor IM, Lotufo PA, et al. Migraine and coronary heart disease in women and men. Headache. 2002;42:715-727.
5. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA. 2006;296:283-291.
6. Davey G, Sedgwick P, Maier W, et al. Asociation between migraine and asthma: matched case-control study. Br J Gen Pract. 2002;52:723-727.
7. Sillanpaa M, Aro H. Headache in teenagers: comorbidity and prognosis. Fund Neurol. 2000;15(suppl 3):116-121.
8. Split W, Szydlowska M. Headache in non-insulin dependent diabetes mellitus. Fund Neurol. 1997;12:327-332.
9. Rainero I, Limone P, Ferrero M. Insulin sensitivity is impaired in patients with migraine. Cephalalgia. 2005;25:593-597.
10. St-Pierre AC, Cantin B, Mauriege P, et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ. 2005;172:1301-1305.
11. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study. Circulation. 2003;108:414-419.
12. Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the strong heart study. Diabetes Care. 2003;26:861-867.
13. Takahashi K, Bokura H, Kobayashi S, et al. Metabolic syndrome increases the risk of ischemic stroke in women. Intern Med. 2007;46:643-648.
14. Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke. 2006;37:806-811.
15. Iso H, Sato S, Kitamura A, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke. 2007;38: 1744-1751.
16. Bigal E, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66:545-550.
17. Mattsson P. Migraine headache and obesity in women aged 40-74 years: a population based study. Cephalagia. 2007;27:877-880.
18. Aamodt AH, Stovner LJ, Midthjell K, et al. Headache prevalence related to diabetes mellitus. The head-HUNT study. Eur J Neurol. 2007;14:738-744.
19. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
20. Headache Classification Sub-Committee of the International Headache Society. International classification of headache disorders, 2nd edition. Cephalalgia. 2004;24:1-160.
21. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Arch Gen Psychiatry. 1990;47:849-853.
22. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-349.
23. Rasmussen BK, Jensen R, Schroll M, et al. Epidemiology of headache in a general population-a prevalence study. J Clin Epidemiol. 1991 ;44:1147-1157.
24. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
25. Macgregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache. 2003;43:19-26.
26. Kececi H, Dener S. Epidemiological and clinical characteristics of migraine in Sivas, Turkey. Headache. 2002;42:275-280.
27. Ku M, Silverman B, Prifti N, et al. Prevalence of migraine headaches in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2006;97:226-230.
28. Horev A, Wirguin I, Lantsberg L, et al. A high incidence of migraine with aura among morbidly obese women. Headache. 2005;45:936-938.
29. Peterlin BL, Bigal ME, Tepper SJ, et al. Migraine and adiponectin: is there a connection? Cephalalgia. 2007;27:435-446.
30. Mohammad-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145-1158.
31. Bigal ME, Lipton RB, Holland PR, et al. Obesity, migraine, and chronic migraine. Neurology. 2007;68:1851-1861.
32. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults findings from the third national health and nutrition examination survey. JAMA. 2002;287:356-359.
33. Mitsias PD, Ramadan NM, Levine SR, et al. Factors determining headache at onset of acute ischemic stroke. Cephalalgia. 2006;26:150-157.
34. Cameron NE, Eaton SE, Cotter MA. et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001 ;44: 1973-1988.
35. Kihara M, Low PA. Impaired vasoreactivity to nitic oxide in experimental diabetic neuropathy. Exp Neurol. 1995;32:180-185.
36. Tietjen GE, Herial NA, Hardgrove J, et al. Migraine comorbidity constellations. Headache. 2007;47:857-865.